A nursing student is reviewing the history of drug legislation in the United States. Which legislative act was the first to prohibit the labeling of medicines with false therapeutic claims intended to defraud the public?
A. Pure Food and Drug Act of 1906
B. Harrison Narcotic Act of 1914
C. Sherley Amendment of 1912
D. Federal Food, Drug, and Cosmetic (FDC) Act of 1938
Answer: C. Sherley Amendment of 1912
Rationale: The Sherley Amendment of 1912 was enacted to address the loophole in the Pure Food and Drug Act of 1906, which did not prohibit false therapeutic claims. This amendment specifically made it illegal to label medicines with false claims intended to defraud. The Pure Food and Drug Act of 1906 was the first law to regulate drugs but focused on misbranding and adulteration, not therapeutic claims. The Harrison Narcotic Act of 1914 regulated habit-forming drugs, and the Federal Food, Drug, and Cosmetic (FDC) Act of 1938 required that new drugs be proven safe before marketing.
A patient with a history of seizures is prescribed a medication that is classified as a controlled substance. The nurse knows that the Comprehensive Drug Abuse Prevention and Control Act of 1970 had which of the following effects?
A. It required all drugs to be tested for harmful effects.
B. It mandated that oral contraceptives contain patient information inserts.
C. It categorized drugs based on their abuse and addiction potential.
D. It accelerated the review process for investigational new drugs.
Answer: C. It categorized drugs based on their abuse and addiction potential.
Rationale: The Comprehensive Drug Abuse Prevention and Control Act of 1970, also known as the Controlled Substances Act, established the five schedules (I-V) for controlled substances. This categorization is based on the drug’s potential for abuse and addiction, as well as its accepted medical use. The requirement for testing for harmful effects was part of the Federal Food, Drug, and Cosmetic Act of 1938. The patient package insert requirement for oral contraceptives was established in 1970. The acceleration of the review process for investigational new drugs was a feature of the Food and Drug Administration Modernization Act of 1997.
A nurse is explaining to a new colleague the significance of the Durham-Humphrey Amendment of 1951. Which statement by the new colleague indicates an understanding of this amendment?
A. “This law requires that all medications be free of impurities.”
B. “This law is the reason we have prescription and over-the-counter medications.”
C. “This law established the five schedules for controlled substances.”
D. “This law was passed in response to birth defects from thalidomide.”
Answer: B. “This law is the reason we have prescription and over-the-counter medications.”
Rationale: The Durham-Humphrey Amendment of 1951 is significant because it created the distinction between “prescription” (legend) drugs, which require medical supervision, and “over-the-counter” (OTC) drugs, which can be sold without a prescription. The requirement for medications to be free of impurities was part of the Pure Food and Drug Act of 1906. The five schedules for controlled substances were established by the Comprehensive Drug Abuse Prevention and Control Act of 1970. The law passed in response to the thalidomide tragedy was the Kefauver-Harris Drug Amendments of 1962.
When administering a narcotic medication to a patient, the nurse follows specific protocols for record-keeping. Which act first regulated the use and record-keeping of habit-forming drugs?
A. Kefauver-Harris Drug Amendments of 1962
B. Sherley Amendment of 1912
C. Comprehensive Drug Abuse Prevention and Control Act of 1970
D. Harrison Narcotic Act of 1914
Answer: D. Harrison Narcotic Act of 1914
Rationale: The Harrison Narcotic Act of 1914 was the first federal law to regulate and tax the production, importation, and distribution of opiates and coca products. It required practitioners, manufacturers, and distributors to register and keep records of these drugs. The Kefauver-Harris Drug Amendments of 1962 focused on drug efficacy. The Sherley Amendment of 1912 addressed false therapeutic claims. The Comprehensive Drug Abuse Prevention and Control Act of 1970 replaced and updated previous drug abuse laws.
Question 5
A pharmaceutical company is submitting a new drug for approval. They must provide evidence of the drug’s safety and efficacy before it can be marketed. This requirement is a direct result of which legislation?
A. Federal Food, Drug, and Cosmetic (FDC) Act of 1938
B. Kefauver-Harris Drug Amendments of 1962
C. Durham-Humphrey Amendment of 1951
D. Food and Drug Administration Modernization Act of 1997
Answer: B. Kefauver-Harris Drug Amendments of 1962
Rationale: While the Federal Food, Drug, and Cosmetic (FDC) Act of 1938 required drugs to be proven safe, the Kefauver-Harris Drug Amendments of 1962, passed in the wake of the thalidomide tragedy, added the requirement that manufacturers also prove the efficacy (effectiveness) of their drugs before they could be approved and marketed. The Durham-Humphrey Amendment created the prescription/OTC distinction, and the Food and Drug Administration Modernization Act of 1997 introduced measures to accelerate drug review.
A patient asks the nurse why their oral contraceptive has a detailed information insert. The nurse correctly explains that this is mandated by the:
A. Patient package insert requirement of 1970.
B. Drug Quality and Security Act of 2013.
C. Project BioShield Act of 2004.
D. Food and Drug Administration Modernization Act of 1997.
Answer: A. Patient package insert requirement of 1970.
Rationale: The requirement for patient package inserts (PPIs) was established in 1970, mandating that certain medications, including oral contraceptives, provide patients with information about the drug’s benefits and risks. The other acts listed address different aspects of drug regulation: drug supply chain security (Drug Quality and Security Act), biodefense (Project BioShield Act), and drug review processes (Food and Drug Administration Modernization Act).
In response to the threat of terrorism, which act was established to expedite the review and distribution of treatments for chemical, biological, and nuclear agents?
A. Food and Drug Administration Modernization Act of 1997
B. Drug Quality and Security Act of 2013
C. Project BioShield Act of 2004
D. Comprehensive Drug Abuse Prevention and Control Act of 1970
Answer: C. Project BioShield Act of 2004
Rationale: The Project BioShield Act of 2004 was specifically created to facilitate the development and deployment of medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) agents of terrorism. It provides funding and allows for the expedited review and emergency use of such treatments.
A hospital is implementing a new electronic system to trace prescription drugs throughout the supply chain. This initiative is in compliance with which of the following acts?
A. Kefauver-Harris Drug Amendments of 1962
B. Drug Quality and Security Act of 2013
C. Harrison Narcotic Act of 1914
D. Federal Food, Drug, and Cosmetic (FDC) Act of 1938
Answer: B. Drug Quality and Security Act of 2013
Rationale: The Drug Quality and Security Act of 2013 includes the Drug Supply Chain Security Act (DSCSA), which mandates the implementation of an electronic, interoperable system to track and trace prescription drugs as they are distributed throughout the United States. This is intended to protect consumers from counterfeit, stolen, or contaminated drugs.
The nurse understands that the official authorities for establishing drug standards in the United States, such as the United States Pharmacopeia (USP) and the National Formulary (NF), were designated by which act?
A. Sherley Amendment of 1912
B. Pure Food and Drug Act of 1906
C. Durham-Humphrey Amendment of 1951
D. Harrison Narcotic Act of 1914
Answer: B. Pure Food and Drug Act of 1906
Rationale: The Pure Food and Drug Act of 1906 was the first law to give official status to the United States Pharmacopeia (USP) and the National Formulary (NF), establishing them as the official sources for drug standards in the U.S. This act required that drugs meet the standards of strength, purity, and quality set forth in these publications.
A nurse is preparing to administer morphine for a patient’s severe pain. The nurse understands that morphine is a Schedule II drug, which means it has:
A. A high potential for abuse and no accepted medical use.
B. A high potential for abuse and an accepted medical use with severe restrictions.
C. A lower potential for abuse than Schedule III drugs.
D. A low potential for abuse and is available over-the-counter.
Answer: B. A high potential for abuse and an accepted medical use with severe restrictions.
Rationale: According to the table, Schedule II drugs have a high potential for abuse but also have a currently accepted medical use, though with severe restrictions. Morphine is listed as an example.
Option A describes Schedule I drugs.
Option C describes Schedule IV drugs.
Option D describes Schedule V drugs.
A patient in the emergency department admits to using heroin. The nurse correctly identifies this substance as a Schedule I controlled drug. Which of the following is a key characteristic of Schedule I substances?
A. They have a currently accepted medical use.
B. They have no currently accepted medical use in the United States.
C. They lead to moderate physical dependence.
D. They have a low potential for abuse relative to Schedule IV drugs.
Answer: B. They have no currently accepted medical use in the United States.
Rationale: The primary defining characteristic of Schedule I drugs, as stated in the text, is a high potential for abuse and no currently accepted medical use in the United States. Heroin is provided as a key example.
Options A and C are incorrect as they contradict the definition of Schedule I.
Option D describes Schedule V drugs.
A nurse is administering alprazolam, a Schedule IV drug, to a patient for anxiety. The nurse recognizes that this classification indicates the drug has:
A. A high potential for abuse that may lead to severe psychological dependence.
B. The same abuse potential as codeine combined with acetaminophen.
C. A lower potential for abuse relative to drugs in Schedule III.
D. No potential for abuse or dependence.
Answer: C. A lower potential for abuse relative to drugs in Schedule III.
Rationale: The table defines Schedule IV drugs as having a “lower potential for abuse relative to the drugs in schedule III.” Alprazolam is listed as an example.
Option A describes Schedule II drugs.
Option B is incorrect; codeine with acetaminophen is a Schedule III drug, which has a higher abuse potential than Schedule IV drugs.
Option D is incorrect as Schedule IV drugs may lead to limited dependence.
A nursing student is reviewing the different schedules of controlled substances. Which of the following drug examples correctly matches its schedule classification?
A. Heroin - Schedule II
B. Morphine - Schedule III
C. Anabolic steroids - Schedule III
D. Diazepam - Schedule V
Answer: C. Anabolic steroids - Schedule III
Rationale: The table explicitly lists anabolic steroids as an example of a Schedule III controlled substance.
Heroin is a Schedule I drug.
Morphine is a Schedule II drug.
Diazepam is a Schedule IV drug.
A patient asks about purchasing an over-the-counter cough medicine that contains a small amount of codeine. The nurse understands that this medication falls under which schedule of controlled substances?
A. Schedule II
B. Schedule III
C. Schedule IV
D. Schedule V
Answer: D. Schedule V
Rationale: The table provides “Over-the-counter (OTC) cough medicines with codeine” as a specific example of a Schedule V drug. This schedule has a low potential for abuse relative to other scheduled drugs, which allows for some preparations to be available without a prescription.
A nurse is preparing to administer a medication to a patient. Which of the following statements best defines the medication’s therapeutic effect?
A. The passage of the drug from the site of administration into the bloodstream.
B. The movement of the medication from the blood into the body’s tissues and organs.
C. The desired result or intended action of a medication on physiologic function.
D. The way the medication is altered into a less active form to prepare for excretion.
Answer: C. The desired result or intended action of a medication on physiologic function.
Rationale: The highlighted text defines the therapeutic effect as “the desired result or action of a medication.”
Option A defines absorption.
Option B defines distribution.
Option D defines metabolism.
A physician has ordered a new medication for a patient to be administered intravenously (IV). The nurse understands that this route is chosen over an oral route when a rapid onset of action is desired because:
A. Oral medications have a higher rate of excretion from the body.
B. IV administration results in the quickest rate of absorption into the bloodstream.
C. Oral medications are more likely to be affected by the patient’s age.
D. IV administration is less dependent on blood flow to the administration site.
Answer: B. IV administration results in the quickest rate of absorption into the bloodstream.
Rationale: The text explicitly states, “Administration of a medication intravenously, or directly into a blood vessel, results in the quickest rate of absorption…” This rapid absorption leads to a faster onset of action. The other options are incorrect or not the primary reason for choosing the IV route for speed.
A nurse is caring for an older adult patient with chronic kidney disease. When reviewing the patient’s prescribed medications, the nurse must consider that the medication’s effectiveness will be most influenced by which factor mentioned in the text?
A. The ability of the drug to dissolve.
B. The patient’s body surface area.
C. The function of metabolizing organs.
D. The blood flow to the administration site.
Answer: C. The function of metabolizing organs.
Rationale: The text states that effectiveness is influenced by the “function of metabolizing organs (such as the liver or kidneys).” Since the patient has chronic kidney disease, the function of this key organ is impaired, which will significantly impact the medication’s effect and excretion. The other options are factors that primarily affect absorption.
A nursing instructor asks a student to identify the process of absorption. Which of the following statements by the student indicates a correct understanding?
A. “Absorption is how a medication is delivered to a specific site of action.”
B. “Absorption is the passage of a drug from the administration site into the bloodstream.”
C. “Absorption is the time it takes for a medication to produce a response.”
D. “Absorption is the process by which a drug is altered to prepare for excretion.”
Answer: B. “Absorption is the passage of a drug from the administration site into the bloodstream.”
Rationale: This is the precise definition of absorption provided in the highlighted text.
Option A describes distribution.
Option C relates to the onset of action.
Option D describes metabolism.
When comparing medication administration routes, which route would the nurse expect to have the slowest rate of absorption?
A. Intravenous
B. Intramuscular
C. Subcutaneous
D. Oral
Answer: D. Oral
Rationale: The text provides a clear hierarchy for the rate of absorption, stating it is quickest for intravenous, “followed in descending order by intramuscularly, subcutaneously, and orally administered medications.” This identifies the oral route as the slowest among the options provided.
A nurse is administering medication to an older adult patient with impaired liver function. The nurse recognizes this patient is at an increased risk for medication toxicity primarily because of a potential decrease in:
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: C. MetabolismRationale: The text states, “Most metabolism takes place in the liver, which may be slowed in elderly individuals or anyone with impaired liver function.” It further explains that if the liver cannot break the drug down, “toxic levels of a medication can build up.” The patient’s conditions (older adult, impaired liver function) directly point to an impairment in metabolism. While excretion can also be affected by age, it is primarily a function of the kidneys.
A patient with chronic kidney disease is prescribed a new medication. The nurse anticipates that the prescriber will make which adjustment to the dosage regimen to prevent adverse effects?
A. Prescribe a larger dose of the medication.
B. Change the route from oral to intravenous.
C. Prescribe smaller doses or longer durations between doses.
D. Order the medication to be taken on an empty stomach.
Answer: C. Prescribe smaller doses or longer durations between doses.Rationale: The text explicitly states that for people with impaired kidney function, drug accumulation may occur, “necessitating prescription of smaller doses or longer durations between doses.” This adjustment helps prevent the drug from building up to toxic levels when the primary route of excretion is compromised. The other options would not address the problem of impaired excretion.
When providing patient education, the nurse explains that the liver’s primary role in pharmacokinetics is metabolism. Which statement best describes this process?
A. The removal of the less active drug from the body.
B. The delivery of the medication to the body’s tissues.
C. The alteration of a drug into a less active form to prepare for excretion.
D. The passage of a drug from the administration site into the bloodstream.
Answer: C. The alteration of a drug into a less active form to prepare for excretion.Rationale: This is the precise definition of metabolism provided in the first sentence of the highlighted text.
Option A describes excretion.
Option B describes distribution.
Option D describes absorption.
A nursing mother asks if a medication she is taking can be passed to her infant. The nurse’s knowledge is based on the principle that while most drug metabolites are removed by the kidneys, they can also be excreted through:
A. The liver
B. The pancreas
C. The circulatory system
D. Breast milk
Answer: D. Breast milkRationale: The section on excretion states that while most metabolites exit through the kidneys, “some may be excreted in feces, breath, saliva, sweat, and breast milk.” The liver is the primary site of metabolism, not excretion.
The nurse is aware that both elderly patients and those with impaired kidney function require careful medication monitoring. This is because both groups are at high risk for which of the following?
A. Rapid absorption of the medication.
B. Accumulation of the drug to unwanted levels.
C. Decreased therapeutic effect of the drug.
D. An allergic reaction to the medication.
Answer: B. Accumulation of the drug to unwanted levels.Rationale: The text on excretion specifies, “The drug may accumulate to unwanted levels in elderly individuals and people with impaired kidney function…” Similarly, the text on metabolism notes that slowed function in the elderly can cause “toxic levels of a medication to build up.” Therefore, accumulation is the primary risk for these populations. A decreased therapeutic effect is the opposite of the expected outcome, and rapid absorption or allergic reactions are unrelated to impaired metabolism and excretion.